Target intelligence / Profile preview

Thrombus

Molecular classification
Other
01

Overview

A thrombus is a blood clot formed from platelets, fibrin, and blood cells within the vascular system. It normally forms as a healthy response to blood vessel injury to prevent bleeding (hemostasis), but can become harmful when it obstructs blood flow (thrombosis), potentially leading to tissue ischemia or infarction. Thrombi can form in veins (venous thrombosis, e.g., deep vein thrombosis) or arteries (arterial thrombosis, e.g., stroke, heart attack). If a piece of thrombus breaks off and travels through the bloodstream, it becomes an embolus and can cause life-threatening complications such as pulmonary embolism or stroke. A thrombus is not a specific molecule, receptor, or protein, but rather the physical end product of the coagulation and hemostasis process involving multiple molecular players (e.g., fibrin, platelets, coagulation factors). Thus, it is not itself a target for drug discovery, but its formation and consequences are key therapeutic and diagnostic considerations in cardiovascular and hematological medicine.

Other names
Blood clotintravascular clotcruor
02

Mechanism of action

Inhibition of coagulation cascade (prevents new clot formation); Enhancement of fibrinolysis (breaks down existing clots); Inhibition of platelet aggregation (prevents clot growth)

03

Biological functions

HemostasisBlood flow obstructionTissue ischemia (when blocking vessels)
04

Disease associations

Cardiovascular diseaseStrokeHeart attack (myocardial infarction)Pulmonary embolismDeep vein thrombosis
05

Safety considerations

Risk of bleeding with anticoagulants/thrombolyticsRecurrent thrombosis if under-treatedEmbolization (risk of clot migrating to critical organs such as lungs, brain, heart)
06

Interacting drugs

Heparin

4 more in the full profile.

07

Biomarkers

D-dimer (used in diagnosis of thrombosis)Platelet countCoagulation factors (e.g., PT/INR, aPTT)

Beyond the preview

Go deeper on Thrombus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call